Ancora Advisors, LLC Nuo Therapeutics, Inc. Transaction History

Ancora Advisors, LLC

  • $3.73 Billion
  • Q2 2024

A detailed history of Ancora Advisors, LLC transactions in Nuo Therapeutics, Inc. stock. As of the latest transaction made, Ancora Advisors, LLC holds 4,700 shares of AURX stock, worth $2,491. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,700
Previous 4,700 -0.0%
Holding current value
$2,491
Previous $4,000 75.0%
% of portfolio
0.0%
Previous 0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$0.45 - $2.75 $2,115 - $12,925
4,700 New
4,700 $13,000

Others Institutions Holding AURX

# of Institutions
1
Shares Held
4.7K
Call Options Held
0
Put Options Held
0
View Full List

About Nuo Therapeutics, Inc.

AURX Quotes by TradingView
  • Ticker AURX
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,799,000
  • Market Cap $22.2M
  • Description
  • Nuo Therapeutics, Inc., a regenerative therapies company, develops, commercializes, and markets cell-based technologies that harness the regenerative capacity of the human body to trigger natural healing primarily in the United States. Its technology separates autologous blood to produce a platelet based therapy for the chronic wound care market...
More about AURX
Track This Portfolio

Track Ancora Advisors, LLC Portfolio

Follow Ancora Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ancora Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ancora Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email